The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial
Abstract
Background and Purpose — We sought to investigate the apparently high risk of early death after an ischemic stroke among patients with atrial fibrillation (AF), identify the main factors associated with early death, and assess the effect of treatment with different doses of subcutaneous unfractionated heparin (UFH) given within 48 hours. Methods — We studied the occurrence of major clinical events within 14 days among 18 451 patients from the International Stroke Trial, first for all treatment groups combined. Then, among patients with AF, we examined the effects of treatment with subcutaneous UFH started within 48 hours and continued until 14 days after stroke onset. Results — A total of 3169 patients (17%) had AF. Seven hundred eighty-four patients were allocated to UFH 12 500 IU SC BID, 773 to UFH 5000 IU SC BID, and 1612 to no heparin. Within each of these groups, half of the patients were randomly assigned to aspirin 300 mg once daily. Compared with patients without AF, patients with AF were more likely to be female (56% versus 45%), to be old (mean age, 78 versus 71 years), to have an infarct on prerandomization CT (57% versus 47%), and to have impaired consciousness (37% versus 20%). The initial ischemic stroke type was more often a large-artery infarct (36% versus 21%). A lacunar stroke syndrome was less common (13% versus 26%). Death within 14 days was more common in patients with AF (17% versus 8%) and more often attributed to neurological damage from the initial stroke (10% versus 4%). The frequency of recurrent ischemic or undefined stroke was not significantly different (3.9% versus 3.3%). The proportion of AF patients with further events within 14 days allocated to UFH 12 500 IU (n=784), UFH 5000 IU (n=773), and to no-heparin (n=1612) groups were as follows: ischemic stroke, 2.3%, 3.4%, 4.9% ( P =0.001); hemorrhagic stroke, 2.8%, 1.3%, 0.4% ( P <0.0001); and any stroke or death, 18.8%, 19.4% and 20.7% ( P =0.3), respectively. No effect of heparin on the proportion of patients dead or dependent at 6 months was apparent. Conclusions — Acute ischemic stroke patients with AF have a higher risk of early death, which can be explained by older age and larger infarcts but not by a higher risk of early recurrent ischemic stroke, although slightly more patients with AF died from a fatal recurrent stroke of ischemic or unknown type (1.3% versus 0.9%). In patients with AF the absolute risk of early recurrent stroke is low, and there is no net advantage to treatment with heparin. These data do not support the widespread use of intensive heparin regimens in the acute phase of ischemic stroke associated with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Self-citationEAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.
Bogousslavsky, J., Van Melle, G., & Regli, F. (1988) · Stroke · doi:10.1161/01.str.19.9.1083 · Cited by 1,350
Chen, Z., Sandercock, P., Pan, H., Counsell, C., Collins, R., Liu, L., Xie, J., Warlow, C., & Peto, R. (2000) · Stroke · doi:10.1161/01.str.31.6.1240 · Cited by 599
Self-citationCardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
ASINGER, R. W., Dyken, M. L., Fisher, M., Hart, R., & Sherman, D. G. (1989) · PubMed · Cited by 548
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment Investigators (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.279.16.1265 · Cited by 530
Berge, E., Abdelnoor, M., Nakstad, P., & Sandset, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02085-7 · Cited by 421
Self-citationCardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force
(1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520430021013 · Cited by 404
Duration of atrial fibrillation and imminence of stroke: the Framingham study.
Wolf, P. A., Kannel, W. B., McGee, D. L., Meeks, S. L., Bharucha, N. E., & McNamara, P. M. (1983) · Stroke · doi:10.1161/01.str.14.5.664 · Cited by 337
Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.
(1983) · Stroke · doi:10.1161/01.str.14.5.668 · Cited by 303
Sandercock, P., Bamford, J., Dennis, M., Burn, J., Slattery, J., Jones, L., Boonyakarnkul, S., & Warlow, C. (1992) · BMJ · doi:10.1136/bmj.305.6867.1460 · Cited by 255
Self-citationAguilar, M. I., & Hart, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001927.pub2 · Cited by 252
Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study.
Hart, R. G., Coull, B. M., & Hart, D. (1983) · Stroke · doi:10.1161/01.str.14.5.688 · Cited by 238
Relationship of cardiac disease to stroke occurrence, recurrence, and mortality.
Broderick, J. P., Phillips, S. J., O'Fallon, W. M., Frye, R. L., & Whisnant, J. P. (1992) · Stroke · doi:10.1161/01.str.23.9.1250 · Cited by 219
Infarcts with a cardiac source of embolism in the NINCDS Stroke Data Bank: Historical features
Kittner, S. J., Sharkness, C. M., Price, T. R., Plotnick, G. D., Dambrosia, J. M., Wolf, P. A., Mohr, J. P., Hier, D. B., Kase, C. S., & Tuhrim, S. (1990) · Neurology · doi:10.1212/wnl.40.2.281 · Cited by 151
Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.
Sage, J. I., & Uitert, R. L. V. (1983) · Stroke · doi:10.1161/01.str.14.4.537 · Cited by 147
Thromboembolism in Patients With Atrial Fibrillation
Sherman, D. G., Goldman, L. E., Whiting, R. B., Jurgensen, K., Kaste, M., & Easton, J. D. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050180030011 · Cited by 142
Olsen, T. S., Skriver, E. B., & Herning, M. (1985) · Stroke · doi:10.1161/01.str.16.3.459 · Cited by 115
Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group.
Candelise, L., Pinardi, G., & Morabito, A. (1991) · Stroke · doi:10.1161/01.str.22.2.169 · Cited by 111
Atrial fibrillation, TIAs and completed strokes.
Harrison, M. J., & Marshall, J. K. (1984) · Stroke · doi:10.1161/01.str.15.3.441 · Cited by 91
Cerebral ischemia and atrial fibrillation
Kelley, R. E., Berger, J. R., Alter, M., & Kovacs, A. G. (1984) · Neurology · doi:10.1212/wnl.34.10.1285 · Cited by 76
Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly.
Yamanouchi, H., Tomonaga, M., Shimada, H., Matsushita, S., Kuramoto, K., & TOYOKURA, Y. (1989) · Stroke · doi:10.1161/01.str.20.12.1653 · Cited by 61
GUSTAFSSON, C., & Britton, M. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00400.x · Cited by 35
Lone atrial fibrillation and stroke
Bogousslavsky, J., Adnet‐Bonte, C., Regli, F., van Melle, G., & KAPPENBERGER, L. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb01605.x · Cited by 15
Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study
Yamanouchi, H., Shimada, H., Tomonaga, M., & Matsushita, S. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03853.x · Cited by 13
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Marini, C., De Santis, F., Sacco, S., Russo, T., Olivieri, L., Totaro, R., & Carolei, A. (2005) · Stroke · doi:10.1161/01.str.0000166053.83476.4a · Cited by 949
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Metadata
- Authors
- Saxena, R., Lewis, S., Berge, E., Sandercock, P. A. G., Koudstaal, P. J., & for the International Stroke Trial Collaborative Group
- Venue
- Stroke
- Published
- 2001-10
- Volume
- 32
- Issue
- 10
- Pages
- 2333-2337
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2097730817
- Cited by
- 290
- References
- 26
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.